During the last session, Microbot Medical Inc (NASDAQ:MBOT)’s traded shares were 1.21 million, with the beta value of the company hitting 1.43. At the end of the trading day, the stock’s price was $1.52, reflecting an intraday loss of -4.40% or -$0.07. The 52-week high for the MBOT share is $3.38, that puts it down -122.37 from that peak though still a striking 46.05% gain since the share price plummeted to a 52-week low of $0.82. The company’s market capitalization is $52.81M, and the average intraday trading volume over the past 10 days was 0.96 million shares, and the average trade volume was 4.24 million shares over the past three months.
Microbot Medical Inc (MBOT) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. MBOT has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.15.
Microbot Medical Inc (NASDAQ:MBOT) trade information
Microbot Medical Inc (MBOT) registered a -4.40% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -4.40% in intraday trading to $1.52, hitting a weekly high. The stock’s 5-day price performance is -8.98%, and it has moved by 0.00% in 30 days. Based on these gigs, the overall price performance for the year is 27.73%. The short interest in Microbot Medical Inc (NASDAQ:MBOT) is 5.13 million shares and it means that shorts have 3.49 day(s) to cover.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 15.51%. While earnings are projected to return 26.76% in 2025.
MBOT Dividends
Microbot Medical Inc is due to release its next quarterly earnings on 2025-Mar-24. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Microbot Medical Inc (NASDAQ:MBOT)’s Major holders
Microbot Medical Inc insiders own 1.62% of total outstanding shares while institutional holders control 7.47%, with the float percentage being 7.60%. VANGUARD GROUP INC is the largest shareholder of the company, while 45.0 institutions own stock in it. As of 2024-06-30, the company held over 0.46 million shares (or 3.2694% of all shares), a total value of $0.47 million in shares.
The next largest institutional holding, with 0.14 million shares, is of BLACKROCK INC.’s that is approximately 0.9253% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $0.14 million.
